Antibody Drug Conjugates Market Trends: The Future of Precision Oncology
The biopharmaceutical sector is currently witnessing a paradigm shift, with the Antibody Drug Conjugates Market Trends pointing toward a new era of highly individualized cancer care. By integrating the targeting capabilities of monoclonal antibodies with the cell-killing strength of cytotoxic payloads, ADCs have redefined what is possible in oncology. This technology is no longer just an...
0 Comentários 0 Compartilhamentos 10 Visualizações 0 Anterior